glp-1 approved for pediatrics FDA-approved medications pediatric obesity Weight loss drugs for kids:

These conditions were not expected to have any connection with the use of GLP-1 RAs, and the outcomes revealed no meaningful associations between any of them and the use of GLP-1 RAs (Figure S4-5)

GLP-1R agonists GLP-1R agonists exert GLP-1 activity and are resistant to DPP-4 degradation

A separate rapid review published in Obesity Reviews in late 2025 by Jebeile and colleagues, which analyzed 25 studies, found that binge eating episodes and prevalence were reduced following treatment with liraglutide and semaglutide

Do I need more electrolytes on Ozempic than before

Centrally, they act on hypothalamic and brainstem nuclei to reduce appetite and increase satiety

This may be plausible given the interspersed heterologous contact between alfa- and beta-cells in the pancreas of primates (89, 90), and the possibility that beta-cells may have cytoplasmic extensions that span alfa-cells (89)